Board of Directors

Peter Francis LLB Grad Dip (Intellectual Property) non-executive Chairman

Appointed 23 Feb 2006.

Mr Peter Francis is a partner at Francis Abourizk Lightowlers (FAL), a firm of commercial and technology lawyers with offices in Melbourne and Brisbane, Australia. He is a legal specialist in the areas of intellectual property and licensing and provides legal advice to a large number of corporations and research bodies. Mr Francis has extensive experience in technology commercialisation and is a Non-executive Director of Xceed Biotechnology Ltd and PolyNovo Biomaterials Ltd, and was a founder of Boron Molecular Pty Ltd.

Dr Ken Reed FATSE BSc MSc PhD non-executive Director

Appointed 19 May 2000.

Dr Ken Reed was the scientific founder of Benitec, whose gene silencing technology came from research conducted at the Queensland Agricultural Biotechnology Centre (QABC) and CSIRO. Dr Reed was the founding director of QABC and previously a co-founder of Advanced Breeding Technology Pty Ltd, the first company to commercialize the use of PCR. He was Deputy Chair of the inaugural Australian Biotechnology Advisory Council and served for many years on the Australian Government's Genetic Manipulation Advisory Committee and the board of the Australian Genome Research Facility.

Dr Reed is a Fellow of the Academy of Technological Sciences and Engineering.

Mel Bridges BAppSc FAICD non-executive Director

Appointed 12 October 2007.

Mr Mel Bridges has more than 30 years experience in the global biotechnology and healthcare industry. During this period, he founded and managed successful diagnostics, biotechnology and medical device businesses. Mel is currently Chairman of a number of listed and unlisted companies. He is Chairman of blue-chip biotech Alchemia Ltd and until recently was Chairman of Peptech Ltd. He is also the founder and a Non-Executive Director of the medical device group Impedimed Pty Ltd. He also co-founded the listed company Panbio Ltd.

The businesses that Mel has founded have won numerous awards including the Queensland Export Award, Australian Small Business of the Year, Queensland Top 400, BRW's Top 100 Fastest Growing Companies for seven consecutive years and The Australian Quality Award. Mel has won numerous awards for his achievements including the Ernst and Young 2002 Entrepreneur of the Year. In 2004 he was anointed the Queensland Entrepreneur of the Year, and in 2005 industry group AusBiotech awarded him the Chairman’s Industry Gold Medal for contributions to the Australian biotech industry.

Sue MacLeman Chief Executive Officer (CEO)

Appointed 1 July 2007.

Ms Sue MacLeman has extensive international senior management and leadership experience in product development and commercialisation in the biotechnology and pharmaceutical sector.

Sue graduated with a Bachelor of Pharmacy from the University of Queensland in 1984. In addition to pharmacy qualifications, Sue MacLeman has completed a Fellowship with the Australian College of Pharmacy Practice, Masters of Marketing at Melbourne University (Melbourne Business School) and is currently enrolled in a Masters of Commercial Law at Deakin University. She is also a Fellow of the Australian Institute of Company Directors and is a Director of AusBiotech Ltd.

In 1991 Sue joined the pharmaceutical industry with Schering Plough in the biotechnology business unit. She then went on to work with Amgen Inc and Bristol Myers Squibb Pharmaceuticals in the areas of medical, marketing, sales management and business development. In 2002 Sue took up the position of global Vice President for Agenix Ltd where she was responsible for the product development of the molecular clot imaging project. From 2004 to 2006 she was the CEO of a publicly listed biotechnology and investment company EQiTX Ltd. Sue joined Benitec Ltd as CEO in September 2006.